Mark Warner is having a busy news week. He's calling the Iran conflict a "war of choice" that Congress never authorized. He's fuming that Trump pulled out of a housing-bill signing ceremony at the last minute, leaving chairs set up and Virginians hanging. And somewhere in between the press hits and the floor votes, he filed disclosure paperwork showing he bought eight individual stocks and sold three index funds, all on the same day: April 13, 2026. That's a lot of activity for a man publicly presenting himself as the adult in the room.
The April 13 Cluster
Eleven trades in one day. Eight purchases, three sales. The buys: Wells Fargo, Microsoft, Blackstone, Rocket Companies, Toast, Atlassian, Accenture, and Constellation Energy. The sales: two broad index funds (iShares Russell 1000 Growth and iShares Russell 1000 Value) and a Vanguard growth ETF. Every single one filed as $1,000 to $15,000.
The move reads like someone who decided April 13 was the day to rotate out of passive index exposure and into individual names. Warner dumped three diversified ETFs and replaced them with a curated eight-stock list spanning fintech, big tech, private equity, mortgage origination, restaurant software, enterprise collaboration, consulting, and nuclear power. That's a portfolio opinion expressed in eleven transactions.
What was happening in the broader market on April 13, 2026? The context matters. April 2026 saw continued volatility from ongoing tariff policy uncertainty, the kind of chop that shakes passive holders loose and creates entry points for people who think they know something about individual names. Warner bought into that dip. Whether that reflects conviction, advice, or timing is not something the disclosure tells you. It just tells you he moved.
The Committee Overlap Problem
Warner sits on the Senate Committee on Banking, Housing, and Urban Affairs, including its subcommittees on Digital Assets, Financial Institutions and Consumer Protection, and Securities, Insurance, and Investment. He also sits on Finance and Intelligence. That's a wide net.
Two of his April 13 purchases land directly inside that net.
Wells Fargo is a bank. Warner is on the Banking Committee. He bought Wells Fargo on April 13, 2026. The 30-day alpha on that trade came in at negative 8.7%. So the committee-overlap purchase didn't exactly print. But the structure of the trade is still the structure of the trade.
Microsoft is a technology company with significant federal contracting exposure, cloud infrastructure, and AI policy implications that run through committee jurisdiction Warner holds. He bought Microsoft on April 13. That trade returned positive 6.3% alpha over 30 days. His Fifth Third Bancorp purchase from March 20 (also squarely in Banking Committee territory) posted 7.8% alpha.
Three committee-overlap trades. Two positive, one negative. The record is not a triumphant one. But the overlap is the overlap, and the full disclosure record is public.
The Amgen Situation
Pull back to the broader 90-day window and the worst trades in the scored sample are hard to ignore. Warner sold Amgen on April 6 and again on April 7, 2026. Those two sales posted 30-day alphas of negative 14.4% and negative 12.9%, respectively. He sold, and then Amgen went up relative to the market. Significantly.
The committee overlap listed for both Amgen trades is "Biotechnology." Warner's Finance Committee assignment covers health care. That's an adjacent remit, not a direct one, and we're not going to overreach on the jurisdiction question. What we can say: he sold a major biotech name twice in consecutive days, and the timing cost him alpha. By the 30-day mark, those sales looked wrong.
The worst single trade in the scored sample is not Amgen, though. It's a March 20 sale of Cheniere Energy with negative 20.1% alpha. No committee overlap flagged on that one. Just a bad call.
The Full Scorecard
The trade alpha record across the full scored sample: 13 positive out of 30 scored trades. Seventeen negative. Mean 30-day alpha of negative 1.5%. That's the number. Not a highlight reel, not a run of winners. Thirteen for thirty, and underwater on average.
The outlier in the positive column is Atlassian, the enterprise software company. Warner bought it on April 13, same day as the rest of the cluster, and posted 47.3% alpha over 30 days. No committee overlap flagged on that trade. Atlassian makes collaboration software for software teams, which has nothing to do with Banking, Finance, or Intelligence in any direct regulatory sense. The trade just worked. It's in the data. It doesn't carry a conflict angle. It's also the single best trade in the scored sample by a factor of more than five over the next-best entry.
Rocket Companies, the mortgage origination platform, posted 8.5% positive alpha from the same April 13 batch. No committee overlap flagged there either. Warner owns a mortgage-adjacent name while simultaneously voting yes on the 21st Century ROAD to Housing Act three times in June. Rocket Companies is a mortgage originator. The Housing Act is about housing. Warner's Banking Committee assignment explicitly covers housing and urban affairs.
There are no flagged vote-trade overlaps in the data for that specific combination. The purchase was April 13. The votes were June 16, 18, and 22. The sequencing runs purchase-then-vote, not vote-then-purchase. The calendar is what the calendar is.
What Warner Is Saying in Public
On Iran: Warner voted yes on the War Powers resolution directing removal of U.S. Forces from hostilities with Iran on June 23, and voted yes on the motion to proceed on the Senate joint resolution to the same effect on June 24 (that motion failed). He's been vocal about his concerns regarding the administration's unilateral posture. The Intelligence Committee assignment makes that beat his lane in a way that most members' floor votes don't carry.
On housing: Warner voted yes three times in June on the 21st Century ROAD to Housing Act, watched Trump cancel the signing ceremony, and went public about it. The Banking Committee is where housing legislation lives. That's his remit. He bought Rocket Companies in April.
The connections are not linear. The disclosure record doesn't come with a memo explaining intent. What it comes with is dates, tickers, and amounts, and anyone can read them in the same order Warner filed them.
The Institutional Reality
Members are required to disclose within 45 days of a transaction. They are not required to divest, recuse, abstain, or acknowledge the irony. The STOCK Act passed in 2012 and the compliance infrastructure has been, let's say, aspirational in practice.
Warner has been in the Senate since 2009. He was a venture capitalist before that, a genuinely wealthy man who got there by knowing how to read a position. The trades in his disclosure filings don't look like someone who handed everything to a blind trust and forgot about it. Eleven trades in one day, across eight individual names, with a clear rotation out of passive index funds. That's an active portfolio manager who happens to also chair Intelligence Committee hearings on threats to the 2026 elections.
The math across 30 scored trades says he's running below market on average. The Atlassian position says sometimes he's very right. The Amgen sales say sometimes he's very wrong. The Wells Fargo purchase from a Banking Committee member says the disclosure system is doing exactly what it was designed to do: surface the information and let everyone else decide what it means.
The receipts are public. Make of them what you make of them.